Cytodyn Inc (CYDY)

[Badge04]

For Shirley and others diminishing the preliminary results…

The purpose of phase 2 is to establish subjective scoring and bio markers that can be reliably followed to ensure a proper phase 3 study population and endpoints. The phase 3 study design will need to be approved. You think the FDA/NIH who have struggled to establish clear definitions of long haulers are going to deny the data provided evaluating the exact patient population they need information on??? Oh ok…